← FDA Drug Approvals (Drugs@FDA)

TARGINIQ

NDA · New Drug Application · Sponsor: PURDUE PHARMA LP · Approved 2014-07-23

Drug application

FDA Application #

NDA205777

Application type

New Drug Application

Brand name

TARGINIQ

Generic name

Naloxone Hydrochloride

Active ingredients

NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

PURDUE PHARMA LP

First approval

2014-07-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown